Differences in transcriptional activity of cutaneous human papillomaviruses

Virus Research

Volumn 137, Issue 2, 2008, Pages 213-219

  Vasiljević, Nataša ^a   Nielsen, Lone ^b   Doherty, Geoff ^a   Dillner, Joakim ^a   Forslund, Ola ^a   Norrild, Bodil ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cutaneous HPV; Differentiation; Promoter; URR; UV B

Indexed keywords

RESTRICTION ENDONUCLEASE;

ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; GENE MAPPING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMA VIRUS TYPE 38; HUMAN PAPILLOMA VIRUS TYPE 8; HUMAN PAPILLOMA VIRUS TYPE 92; HUMAN PAPILLOMA VIRUS TYPE 93; HUMAN PAPILLOMA VIRUS TYPE 96; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; SEROTYPE; SKIN CANCER; SKIN PAPILLOMA; TRANSCRIPTION INITIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION; UPREGULATION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BASE SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; SKIN; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; ULTRAVIOLET RAYS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 53749083668     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2008.07.013     Document Type: Article

References (39)

1. Akgul B., Lemme W., Garcia-Escudero R., Storey A., and Pfister H.J. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch. Virol. 150 1 (2005) 145-151
2. Alam M., and Ratner D. Cutaneous squamous-cell carcinoma. N. Engl. J. Med. 344 13 (2001) 975-983
3. Antonsson A., Forslund O., Ekberg H., Sterner G., and Hansson B.G. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J. Virol. 74 24 (2000) 11636-11641
4. Apt D., Watts R.M., Suske G., and Bernard H.U. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology 224 1 (1996) 281-291
5. Braunstein T.H., Madsen B.S., Gavnholt B., Rosenstierne M.W., Johnsen C.K., and Norrild B. Identification of a new promoter in the early region of the human papillomavirus type 16 genome. J. Gen. Virol. 80 Pt 12 (1999) 3241-3250
6. Caldeira S., Zehbe I., Accardi R., Malanchi I., Dong W., Giarre M., de Villiers E.M., Filotico R., Boukamp P., and Tommasino M. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J. Virol. 77 3 (2003) 2195-2206
7. Casabonne D., Michael K.M., Waterboer T., Pawlita M., Forslund O., Burk R.D., Travis R.C., Key T.J., and Newton R. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European prospective investigation into cancer and nutrition. Int. J. Cancer 121 8 (2007) 1862-1868
8. Cheng S., Schmidt Grimminger D.C., Murant T., Broker T.R., and Chow L.T. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9 19 (1995) 2335-2349
9. De Marco F., Perluigi M., Foppoli C., Blarzino C., Cini C., Coccia R., and Venuti A. UV-B irradiation down-regulates HPV-16 RNA expression: implications for malignant progression of transformed cells. Virus Res. 130 1-2 (2007) 249-259
10. de Villiers E.-M., Fauquet C., Broker T.R., Bernard H.-U., and zur Hausen H. Classification of papillomaviruses. Virology 324 1 (2004) 17-27
11. de Villiers E.M., Ruhland A., and Sekaric P. Human papillomaviruses in non-melanoma skin cancer. Semin. Cancer Biol. 9 6 (1999) 413-422
12. Ensser A., and Pfister H. Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genome region. Nucleic Acids Res. 18 13 (1990) 3919-3922
13. Forslund O., Antonsson A., Higgins G., Ly H., Delius H., Hunziker A., and Villiers E.M. Nucleotide sequence and phylogenetic classification of candidate human papilloma virus type 92. Virology 312 2 (2003) 255-260
14. Forslund O., Iftner T., Andersson K., Lindelof B., Hradil E., Nordin P., Stenquist B., Kirnbauer R., Dillner J., and de Villiers E.M. Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous sell carcinoma. J. Infect. Dis. 196 6 (2007) 876-883
15. Garcia-Vallve S., Iglesias-Rozas J.R., Alonso A., and Bravo I.G. Different papillomaviruses have different repertoires of transcription factor binding sites: convergence and divergence in the upstream regulatory region. BMC Evol. Biol. 6 (2006) 20
16. Geisen C., and Kahn T. Promoter activity of sequences located upstream of the human papillomavirus types of 16 and 18 late regions. J. Gen. Virol. 77 Pt 9 (1996) 2193-2200
17. Gniadecki R., Olszewska H., and Gajkowska B. Changes in the ultrastructure of cytoskeleton and nuclear matrix during HaCaT keratinocyte differentiation. Exp. Dermatol. 10 2 (2001) 71-79
18. Haller K., Stubenrauch F., and Pfister H. Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. Virology 214 1 (1995) 245-255
19. Jackson S., Harwood C., Thomas M., Banks L., and Storey A. Role of bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 14 23 (2000) 3065-3073
20. Jensen U.B., Petersen M.S., Lund T.B., Jensen T.G., and Bolund L. Transgene expression in human epidermal keratinocytes: cell cycle arrest of productively transfected cells. Exp. Dermatol. 9 4 (2000) 298-310
21. Karagas M.R., Nelson H.H., Sehr P., Waterboer T., Stukel T.A., Andrew A., Green A.C., Bavinck J.N., Perry A., Spencer S., Rees J.R., Mott L.A., and Pawlita M. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J. Natl. Cancer Inst. 98 6 (2006) 389-395
22. Kiviat N.B. Papillomaviruses in non-melanoma skin cancer: epidemiological aspects. Semin. Cancer Biol. 9 6 (1999) 397-403
23. Lehman T.A., Modali R., Boukamp P., Stanek J., Bennett W.P., Welsh J.A., Metcalf R.A., Stampfer M.R., Fusenig N., Rogan E.M., et al. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14 5 (1993) 833-839
24. Majewski S., and Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus- induced genetic cancer of the skin. Arch. Dermatol. 131 11 (1995) 1312-1318
25. Mistry N., Simonsson M., and Evander M. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin. Virol. J. 4 (2007) 27
26. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., and Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 6 (2003) 518-527
27. Orth G., Jablonska S., Favre M., Croissant O., Jarzabek Chorzelska M., and Rzesa G. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc. Natl. Acad. Sci. U.S.A 75 3 (1978) 1537-1541
28. Pfister H. Chapter 8: Human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr. 31 (2003) 52-56
29. Pfister H., and Ter Schegget J. Role of HPV in cutaneous premalignant and malignant tumors. Clin-Dermatol. 15 3 (1997) 335-347
30. Quinlan R.A., Schiller D.L., Hatzfeld M., Achtstatter T., Moll R., Jorcano J.L., Magin T.M., and Franke W.W. Patterns of expression and organization of cytokeratin intermediate filaments. Ann. N. Y. Acad. Sci. 455 (1985) 282-306
31. Rohlfs M., Winkenbach S., Meyer S., Rupp T., and Durst M. Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16. Virology 183 1 (1991) 331-342
32. Sailaja G., Watts R.M., and Bernard H.U. Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers. J. Gen. Virol. 80 Pt 7 (1999) 1715-1724
33. Scheurlen W., Gissmann L., Gross G., and zur Hausen H. Molecular cloning of two new HPV types (HPV 37 and HPV 38) from a keratoacanthoma and a malignant melanoma. Int. J. Cancer 37 4 (1986) 505-510
34. Smotkin D., and Wettstein F.O. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. U.S.A 83 13 (1986) 4680-4684
35. Stubenrauch F., Malejczyk J., Fuchs P.G., and Pfister H. Late promoter of human papillomavirus type 8 and its regulation. J. Virol. 66 6 (1992) 3485-3493
36. Vasiljevic N., Hazard K., Eliasson L., Ly H., Hunziker A., de Villiers E.M., Norrild B., Dillner J., and Forslund O. Characterization of two novel cutaneous human papillomaviruses, HPV93 and HPV96. J. Gen. Virol. 88 Pt 5 (2007) 1479-1483
37. Woodman C.B., Collins S.I., and Young L.S. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 7 1 (2007) 11-22
38. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288 2 (1996) F55-78
39. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 5 (2002) 342-350